The Justice Department alleges that Chief Executive Ruthia He and company clinical President David Brody schemed to provide easy access to Adderall and other stimulants to patients who didn't need them - then billed insurance companies for the medication.
Prosecutors allege that He and Brody arranged for the prescription of more than 40 million pills, including Adderall, and generated more than $100 million in revenue since the beginning of the COVID-19 pandemic.
The charges coincide with an ongoing shortage of several stimulant medications commonly prescribed to treat ADHD, according to the U.S. Centers for Disease Control and Prevention.
"Instead of properly addressing medical needs, the defendants allegedly made millions of dollars by pushing addictive medications," said Anne Milgram, administrator of the U.S. Drug Enforcement Administration.
[
Collection
]
[
|
...
]